TODAY’S NEWS Big news on the leukemia front: Novartis' Tasigna gets priority FDA review for newly-diagnosed patients; and Roche/Genentech's Rituxan approved for CLL. A quarter of new prescriptions …
Impactiviti Daily 100509
TODAY’S NEWS Spitting into the wind - Allergan sues the FDA about freedom of speech (esp. off-label discussions). This particular legal discussion needs to happen, actually - but it takes a brass …
Impactiviti Daily 090309
TODAY’S NEWS Sepracor to be purchased by Japanese company, according to report - By purchasing Sepracor, which sells drugs to treat central nervous system and respiratory disorders, Dainippon would …
Today’s Top Pharma News 071009
Roche-Genentech - the cuts begin - Anxiety rippled through Genentech this week as the Swiss drug firm Roche began to cut rank-and-file jobs as it folds the South San Francisco biotech firm into its …
Today’s Top Three in Pharma 060409
OK, so it's a "baker's three" (8) today. Makes up for yesterday's zero...! Patent-holder urges FDA to NOT approve prasugrel (from Lilly/Daiichi Sankyo). Novartis getting cold feet at the Alcon …
Today’s Top Three in Pharma 042309
FDA extends review of AstraZeneca/BMS experimental diabetes drug Onglyza. Teva blocked from launching generic form of Lilly's Evista; also rumored to be eyeballing a purchase of …